1-3 of 3
Sudhir Unni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Patient-Reported Outcomes in Acute Myeloid Leukemia Patients with FLT3 -ITD Mutation Receiving Quizartinib Vs. Standard Chemotherapy: Results from the Quantum-First Trial

Esther Natalie Oliva, Sudhir Unni, Francesco Cottone, Rohan Vashi, Xiaocong Li, Jorge Cortes, Mikkael A. Sekeres
Journal: Blood
Blood (2023) 142 (Supplement 1): 918.
https://doi.org/10.1182/blood-2023-189035
Published: 2023
Journal Articles

Healthcare Utilization and Imputed Costs of Acute Myeloid Leukemia Patients By FLT3 Status and Early Midostaurin Use at a Comprehensive Cancer Center

Minkyoung Yoo, Jyothi Menon, PhD, Connor Willis, PharmD, Sudhir Unni, PhD, Trang Au, PharmD, Joseph Biskupiak, PhD, Briana Ndife, MPH, George J Joseph, BPharm, MS, PhD, Gaetano J Bonifacio, MD, Eytan M. Stein, MD, Srinivas K. Tantravahi, MBBS, Paul J. Shami, MD, Tibor Kovacsovics, MD, Diana Brixner, PhD, David Dean Stenehjem, PharmD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5857.
https://doi.org/10.1182/blood-2018-99-113479
Published: 2018
Journal Articles

Emerging Real-World Midostaurin Treatment Patterns and Outcomes in FLT3-Mutated Acute Myeloid Leukemia at a Comprehensive Cancer Center

Connor Willis, PharmD, Jyothi Menon, PhD, Sudhir Unni, PhD, Trang Au, PharmD, Briana Ndife, MPH, George J Joseph, BPharm, MS, PhD, Gaetano J Bonifacio, MD, Eytan M. Stein, MD, Srinivas K. Tantravahi, MBBS, Paul J Shami, MD, Tibor Kovacsovics, MD, Diana Brixner, PhD, David Dean Stenehjem, PharmD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4745.
https://doi.org/10.1182/blood-2018-99-115009
Published: 2018